Blogs
High-Risk Medications & Evidence-Based Pharmacotherapy
Expert insights on medication safety, clinical research, and evidence-based practice for optimal patient outcomes.
Featured Articles
Latest evidence-based insights
High-Risk Medications Management
Evidence-based strategies for safe use of medications with narrow therapeutic indices
Anticoagulants
Warfarin
High Bleeding RiskVitamin K antagonist with narrow therapeutic index requiring frequent monitoring.
- Regular INR monitoring essential (target 2.0-3.0 for most indications)
- Multiple drug-drug and drug-food interactions
- Consider genetic testing for CYP2C9 and VKORC1 variants
Direct Oral Anticoagulants (DOACs)
Renal Function DependentFactor Xa inhibitors and direct thrombin inhibitors with more predictable pharmacokinetics.
- Renal function assessment critical before initiation and periodically
- Limited reversal agents available
- Dosing varies by indication, renal function, and patient weight
Insulins
Rapid-Acting Insulins
Hypoglycemia RiskInsulin lispro, aspart, glulisine with quick onset and short duration.
- Administer immediately before meals or within 15-20 minutes after starting meal
- Higher risk of hypoglycemia if meals skipped or delayed
- Dosing adjustments based on carbohydrate intake and pre-meal glucose
Long-Acting Insulins
Nocturnal HypoglycemiaInsulin glargine, detemir, degludec with prolonged duration of action.
- Do not mix with other insulins
- Consistent administration time important
- Lower risk of hypoglycemia compared to NPH insulin
Evidence-Based Practice Resources
Tools and frameworks for implementing evidence-based pharmacotherapy
Literature Evaluation
Critical appraisal tools and frameworks for assessing clinical research quality and applicability to practice.
Clinical Decision Support
Integration of evidence-based guidelines into electronic health records and clinical workflows.
Interprofessional Collaboration
Strategies for effective communication and collaboration in medication therapy decision-making.